FDA Drug Application (022223) for TRIESENCE by ALCON RES

Back to FDA Applications sponsored by ALCON RES

Application Number022223
Product Number001
FormINJECTABLE; SUSPENSION
Dosage40MGML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code TBD
Reference Drug
Drug NameTRIESENCE
Active IngredientTRIAMCINOLONE ACETONIDE

Active IngredientCount
List of drugs with Active Ingredient TRIAMCINOLONE ACETONIDE33


Back to FDA Applications sponsored by ALCON RES